Raymond James Financial Services Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,604
Closed -$202K 3129
2020
Q3
$202K Sell
4,604
-27
-0.6% -$1.33K ﹤0.01% 2546
2020
Q2
$205K Sell
4,631
-3,264
-41% -$122K ﹤0.01% 2483
2020
Q1
$283K Buy
7,895
+20
+0.3% +$1.14K ﹤0.01% 1884
2019
Q4
$558K Sell
7,875
-11
-0.1% -$798 ﹤0.01% 1905
2019
Q3
$590K Buy
7,886
+1,125
+17% +$95.4K ﹤0.01% 1796
2019
Q2
$545K Sell
6,761
-366
-5% -$25.7K ﹤0.01% 1870
2019
Q1
$477K Buy
7,127
+333
+5% +$25.2K ﹤0.01% 1929
2018
Q4
$506K Sell
6,794
-3,804
-36% -$314K ﹤0.01% 1661
2018
Q3
$976K Sell
10,598
-559
-5% -$53.2K ﹤0.01% 1480
2018
Q2
$1.1M Buy
11,157
+2,481
+29% +$277K 0.01% 1358
2018
Q1
$967K Buy
8,676
+1,308
+18% +$147K 0.01% 1325
2017
Q4
$758K Buy
7,368
+526
+8% +$52.4K ﹤0.01% 1472
2017
Q3
$644K Buy
+6,842
New +$540K ﹤0.01% 1574

Other funds holding CMD

Raymond James Financial Services Advisors's CMD Position: Q4 2020 in Review

Raymond James Financial Services Advisors sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 4,604 shares — an estimated $202K sold.

Raymond James Financial Services Advisors first reported a position in CMD in Q3 2017 and held it in 13 quarters. The position peaked at $1.1M in Q2 2018. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Raymond James Financial Services Advisors reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4,604 Cantel Medical Corporation shares in Q4 2020, an estimated $202K.
  • Raymond James Financial Services Advisors first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 13 quarters.
  • Raymond James Financial Services Advisors's Cantel Medical Corporation position peaked at $1.1M in Q2 2018.
  • 229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.